Decreased astrocytic CCL5 by Mir324 ameliorates ischemic stroke injury via the CCR5/ERK/CREB pathway

Following ischemic stroke, Ccl5 mRNA expression increased, while Mir324 expression decreased in the peri-infarct cortex of middle cerebral artery occlusion (MCAO) mice. However, the roles of CCL5 and Mir324 in stroke remained largely unclear. Here, we show that inhibiting CCL5 using antibodies or Mir324 not only reduced infarct area and preserved neurological function in MCAO mice but also attenuated astrocyte reactivity and microglial activation, protected dendritic structures, and maintained spine density. In an astrocyte-neuron co-culture system after oxygen-glucose deprivation (OGD), inhibiting astrocytic CCL5 by antibody or Mir324 decreased neuronal apoptosis and preserved dendritic structure. Importantly, the suppression of CCL5 enhanced ERK/CREB pathway signaling both in vivo and in vitro. Consistent with these findings, the application of Maraviroc, a CCR5 antagonist, reduced infarct size, decreased neuronal apoptosis, and upregulated the ERK/CREB pathway in neurons treated with OGD. In conclusion, targeting the CCL5 pathway via Mir324 represents a promising therapeutic strategy for alleviating ischemic stroke damage through modulation of the neuronal CCR5/ERK/CREB pathway.

Authors

Institutions

Publication Details

Journal
eLife
Published
2026-11-19
DOI
https://doi.org/10.7554/elife.101719
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Decreased astrocytic CCL5 by Mir324 ameliorates ischemic stroke injury via the CCR5/ERK/CREB pathway

Jing‐Xiu Li, Xinrui Wang, Chenxi Sun, Chao Li et al.
1 links
eLife
Neuroinflammation and Neurodegeneration Mechanisms
preprint

Decreased astrocytic CCL5 by Mir324 ameliorates ischemic stroke injury via the CCR5/ERK/CREB pathway

Jing‐Xiu Li, Xinrui Wang, Chenxi Sun, Chao Li, Zhiqin Gao, Keyuan Gao, Lili Wang, Xinmiao Ding, Qingchen Ma, Kai Lian, Yubing Wang
preprint en

Abstract

Following ischemic stroke, Ccl5 mRNA expression increased, while Mir324 expression decreased in the peri-infarct cortex of middle cerebral artery occlusion (MCAO) mice. However, the roles of CCL5 and Mir324 in stroke remained largely unclear. Here, we show that inhibiting CCL5 using antibodies or Mir324 not only reduced infarct area and preserved neurological function in MCAO mice but also attenuated astrocyte reactivity and microglial activation, protected dendritic structures, and maintained spine density. In an astrocyte-neuron co-culture system after oxygen-glucose deprivation (OGD), inhibiting astrocytic CCL5 by antibody or Mir324 decreased neuronal apoptosis and preserved dendritic structure. Importantly, the suppression of CCL5 enhanced ERK/CREB pathway signaling both in vivo and in vitro. Consistent with these findings, the application of Maraviroc, a CCR5 antagonist, reduced infarct size, decreased neuronal apoptosis, and upregulated the ERK/CREB pathway in neurons treated with OGD. In conclusion, targeting the CCL5 pathway via Mir324 represents a promising therapeutic strategy for alleviating ischemic stroke damage through modulation of the neuronal CCR5/ERK/CREB pathway.

eLifeVol. 13
Weifang Medical University (CN), Weifang People's Hospital (CN)
National Natural Science Foundation of China, Natural Science Foundation of Shandong Province
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon